Optimization of de novo belatacept-based immunosuppression administered to renal transplant recipients.
Am J Transplant
; 21(5): 1691-1698, 2021 05.
Article
em En
| MEDLINE
| ID: mdl-33128812
Palavras-chave
clinical research / practice; editorial / personal viewpoint; immunosuppressant - fusion proteins and monoclonal antibodies; immunosuppression / immune modulation; immunosuppressive regimens - maintenance; kidney transplantation / nephrology; kidney transplantation: living donor; off-label drug use; rejection: acute
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Transplante de Rim
Tipo de estudo:
Etiology_studies
/
Observational_studies
/
Risk_factors_studies
Limite:
Humans
Idioma:
En
Ano de publicação:
2021
Tipo de documento:
Article